Dr. Richard Jay Drexelius, MD

Dr. Drexelius practices at Prhr Highlands Rch in Highlands Ranch, Colorado.

Dr. Drexelius' NPI, 1780612762, was assigned on June 29, 2006. Dr. Drexelius holds Colorado license 30924.

Dr. Drexelius' primary practice is Prhr Highlands Rch, at 9135 S Ridgeline Blvd, Highlands Ranch, CO 80129 in Douglas County. The practice phone is (303) 649-3140.

Dr. Drexelius' primary practice is Prhr Highlands Rch in Highlands Ranch, Colorado. Dr. Drexelius is also affiliated with AdventHealth Littleton. The medical group on file is AdventHealth Transplant Institute North Billings. Dmand AI also links Dr. Drexelius to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Drexelius practices, 5 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Drexelius' primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Drexelius is licensed in Colorado.

CMS data shows 834 Medicare services from Dr. Drexelius across 8 procedure codes in 2024, for 250 Medicare patients. Medicare paid $26,963 for them. Every service was in an office.

CMS counts 250 Medicare patients who saw Dr. Drexelius in 2024. The largest group is 65 to 74, with 164 patients. 74% of them have high cholesterol, and 53% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.80, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Drexelius' median patient age at 64, with 34% women.

In 2024, Dr. Drexelius wrote 5,634 Medicare Part D claims for 541 patients. 90% of them were for generic drugs. CMS names the drug for 5,028 of them, across 92 drugs with 11 or more claims each, at $269,507 in total drug cost. In 2023, CMS named 4,670 claims across 93 drugs.

Dr. Drexelius accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Drexelius as offering telehealth. CMS counts 54 procedures of removal of skin lesions by Dr. Drexelius, more than 72% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 15 general payments to Dr. Drexelius from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 66% of the total. Sanofi Pasteur Inc. paid the most, $178.